Financial

  • Dec. 22, 2016 biOasis Announces Adoption of Restricted Share Unit Plan

    VANCOUVER, BC–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) announces that subject to approval by the TSX Venture Exchange (“TSXV”) and ratification by the Company’s shareholders at the 2016 Annual and Special General Meeting of shareholders (the “AGM”), the Company adopted a restricted share unit plan (the “RSU Plan”). Further details regarding the RSU… Read more »

  • Apr. 8, 2016 biOasis Technologies Inc. Grants Stock Options

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI)(OTCQB: BIOAF)(the “Company”) announces that pursuant to the Company’s Incentive Stock Option Plan (the “Plan”), it has granted incentive stock options to directors, officers and consultants of the Company to purchase an aggregate of 1,950,000 common shares in the capital stock of the Company. The options are exercisable at… Read more »

  • Feb. 29, 2016 biOasis Announces Shares for Services Settlement

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQB: BIOAF)(the “Company”) wishes to announce its intention to issue 125,000 shares for services to a consultant of the Company that provides certain consulting services related to business development and financial advisory services. The issuance of shares for services will represent payment of consulting fees. The consulting agreement… Read more »

  • Sep. 29, 2015 biOasis Announces Listing on OTCQB Exchange

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQB: BIOAF)(the “Company”) wishes to announce that its current listing on the OTCQX will be changing to a listing on the OTCQB. The Company’s trading symbol will remain BIOAF. The Company remains in compliance with all relevant TSX Venture and OTCQB reporting standards and will continue trading on… Read more »

  • Sep. 5, 2014 biOasis Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work with biOasis

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies, Inc. (OTCQX:BIOAF; TSXV:BTI), announces that the Natural Sciences and Engineering Research Council of Canada (“NSERC”) has awarded a grant to the University of British Columbia (“UBC”) in support of the university’s collaborative research and development programs with biOasis Technologies Inc. The University and biOasis continue to develop biOasis’ extensive… Read more »

  • Aug. 30, 2014 biOasis Closes Non-Brokered Private Placement for $1,609,753.15 Gross Proceeds

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI) (the “Company”) is please to announce it has closed its non-brokered private placement announced on August 8th, 2014. The Company has issued 1,694,447 units (each a “Unit”), including an over allotment of 94,477 Units, at a price of CDN$0.95 per unit, for gross proceeds of CDN$1,609,753.15.… Read more »

  • Aug. 9, 2014 biOasis Announces Non-Brokered Private Placement

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQX: BIOAF)(the “Company”) announces a non-brokered private placement of up to 1,600,000 units (each a “Unit”) at a price of $0.95 per Unit of gross proceeds of up to $1,520,000 with an overallotment of up to 20%. Each Unit will consist of one common share and one… Read more »

  • May. 8, 2014 biOasis Secures DTC Eligibility

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (OTCQX:BIOAF) (TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, today announced that it has secured DTC eligibility by The Depository Trust Company (DTC) for its shares traded on the OTCQX® under the symbol BIOAF. The DTC is a… Read more »

  • Feb. 24, 2014 biOasis to Begin Trading on OTCQX® Marketplace in the U.S.

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (OTCQX:BIOAF) (TSX.V:BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier, has up listed on the highest tier of the off- market, OTCQX® under the symbol BIOAF. “Joining the OTCQX brings greater visibility and awareness of biOasis to the US… Read more »

  • Dec. 4, 2013 Option Grant – biOasis Technologies Inc.

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX: V BTI) (the “Company”) announces that, pursuant to the terms of its Stock Option Plan, the company has granted a total of 1,700,000 options to its officers, employees, consultants and members of the board of directors. 1,550,000 of the options are exercisable at a price of $0.97… Read more »